According to the latest report by IMARC Group, titled, “Microbiome Sequencing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global microbiome sequencing services market size reached US$ 1,537.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 4,612.0 Million by 2027, exhibiting a growth rate (CAGR) of 20.2% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Microbiome sequencing services aid in determining the function of the microbiome in human health and disease pathogenesis by utilizing next-generation sequencing (NGS) instruments. They primarily include functional profiling, alpha-diversity, beta-diversity, virulence factor identification, LEfSe biomarker discovery, clustering heatmap, etc. These services offer comprehensive bioinformatics and statistical analyses in an interactive and user-friendly report, along with faster and more accurate classification compared to conventional identification methods, such as cloning and culturing.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/microbiome-sequencing-services-market/requestsample
Microbiome Sequencing Services Market Trends and Drivers:
The expanding pharmaceutical sector across the globe is among the key factors driving the microbiome sequencing services market. Moreover, the rising prevalence of colorectal cancer (CRC) owing to various factors, including the increasing occurrences of inflammatory intestinal conditions and consumption diets with low fiber and high fat content, is further stimulating the market growth. Apart from this, the escalating demand for early disease detection and diagnosis is further augmenting the global market. Furthermore, the growing applications of microbiome sequencing services in academia and research institutes for protein and small molecule analysis are catalyzing the product demand. Additionally, microbiome content is widely gaining traction as a biomarker for different diseases owing to faster and cost-effective sequencing platforms and data analysis pipelines, which is propelling the market. Besides this, the increasing focus on customizing gut microbial consortia to develop advanced individualized medicine, coupled with advancements in genomic research, are expected to drive the microbiome sequencing services market over the forecasted period.
Microbiome Sequencing Services Market 2022-2027 Competitive Analysis and Segmentation:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
The report has segmented the market based on technology, research type, laboratory type, application and end user.
Breakup by Technology:
Breakup by Research Type:
Breakup by Laboratory Type:
Breakup by Application:
Breakup by End User:
Breakup by Region:
Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/microbiome-sequencing-services-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800